Sabra Healthcare REIT (SBRA) & The Competition Head-To-Head Analysis

Sabra Healthcare REIT (NASDAQ:SBRA) is one of 40 publicly-traded companies in the “Healthcare REITs” industry, but how does it contrast to its peers? We will compare Sabra Healthcare REIT to similar businesses based on the strength of its valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Volatility and Risk

Sabra Healthcare REIT has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Comparatively, Sabra Healthcare REIT’s peers have a beta of 0.85, meaning that their average stock price is 15% less volatile than the S&P 500.

Profitability

This table compares Sabra Healthcare REIT and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sabra Healthcare REIT	7.78%	2.55%	1.30%
Sabra Healthcare REIT Competitors	21.80%	5.02%	2.84%

Valuation & Earnings

This table compares Sabra Healthcare REIT and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sabra Healthcare REIT	$919.09 million	$155.61 million	75.07
Sabra Healthcare REIT Competitors	$1.27 billion	$1.61 million	50.51

Sabra Healthcare REIT’s peers have higher revenue, but lower earnings than Sabra Healthcare REIT. Sabra Healthcare REIT is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and recommmendations for Sabra Healthcare REIT and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sabra Healthcare REIT	0	6	7	1	2.64
Sabra Healthcare REIT Competitors	422	2004	1983	84	2.38

Sabra Healthcare REIT presently has a consensus target price of $21.50, indicating a potential upside of 2.28%. As a group, “Healthcare REITs” companies have a potential upside of 9.71%. Given Sabra Healthcare REIT’s peers higher possible upside, analysts plainly believe Sabra Healthcare REIT has less favorable growth aspects than its peers.

Institutional & Insider Ownership

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 60.4% of shares of all “Healthcare REITs” companies are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by insiders. Comparatively, 3.1% of shares of all “Healthcare REITs” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Dividends

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 5.7%. Sabra Healthcare REIT pays out 428.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Healthcare REITs” companies pay a dividend yield of 4.1% and pay out 165.0% of their earnings in the form of a dividend.

Summary

Sabra Healthcare REIT peers beat Sabra Healthcare REIT on 8 of the 15 factors compared.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.